Biotechnology
Technology
Health

Pacific Biosciences

$7.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.00 (0.07%) Today
+$0.00 (0.07%) Today

Why Robinhood?

You can buy or sell PACB and other stocks, options, ETFs, and crypto commission-free!

About

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Read More It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Employees
401
Headquarters
Menlo Park, California
Founded
2000
Market Cap
1.10B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.89M
High Today
$7.33
Low Today
$7.27
Open Price
$7.31
Volume
28.82K
52 Week High
$7.84
52 Week Low
$2.02

Collections

Biotechnology
Technology
Health
Software Service
US
North America

News

MarketBeatMar 14

Stock Price, News, & Analysis for Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such...

12
Yahoo FinanceMar 13

Pacific Biosciences (PACB) Up 3.8% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Pacific Biosciences of California (PACB). Shares have added about 3.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Pacific Biosciences due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Pacific Bioscie...

55
Seeking AlphaMar 12

Merger Arbitrage Analysis And Spread Performance - March 10, 2019

This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited.

35

Earnings

-$0.26
-$0.22
-$0.17
-$0.13
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.